Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
4.0
-19.88%
40%
—
8.09%
60%
—
5 Years
Score4.0
Net Growth-19.88%
Net Trend40%
Net Income Consistency—
Rev Growth8.09%
Rev Trend60%
Revenue Consistency—
Vivos Therapeutics Inc fundamental performance
Between 2020 and 2025, revenue grew from $ 13M to $ 17M and net income went from -$ 12M to -$ 21M. Revenue increased in 3 of those 5 years; net income in 2.
Vivos Therapeutics Inc currently holds a 5-year HDB Score of 4.0 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 0.29 | — |
1 Year2025-08-12 | $ 4.75 | -93.98% |
5 Years2021-08-12 | $ 68.50 | -99.58% |
All Time2020-12-11 | $ 224.75 | -99.87% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2020-12-11 |
|---|---|---|---|---|
| Price | $ 0.29 | $ 4.75 | $ 68.50 | $ 224.75 |
| Return | — | -93.98% | -99.58% | -99.87% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 18M | -$ 24M | $ 2M |
| 2025 | $ 17M | -$ 21M | $ 2M |
| 2024 | $ 15M | -$ 11M | $ 6M |
| 2023 | $ 13M | -$ 13M | $ 1M |
| 2022 | $ 16M | -$ 23M | $ 3M |
| 2021 | $ 16M | -$ 20M | $ 24M |
| IPO2020 | $ 13M | -$ 12M | $ 18M |
Explore beyond VVOS
You're looking at Vivos Therapeutics Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
